Skip to main content
Total Market Cap: $122,027,944,242 Volume (24h): $9,517,451,054

Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc. (CRBP) logo
Rank 36
About

Corbus Pharmaceuticals is a biopharmaceutical company in its third stage of preclinical trials. Their novel therapeutic treatments are aimed at inflammatory and fibrotic conditions. The primary mechanism for these treatments is the endocannabinoid system and the agitation of CB2 receptors. The company operates out of Norwood, Massachusetts.

Website
$3.3799
USD
10.00%
Market cap
$218,515,919
Total volume
$137,533,973
Shares outstanding
64,651,593
Rank 36
Website
About

Corbus Pharmaceuticals is a biopharmaceutical company in its third stage of preclinical trials. Their novel therapeutic treatments are aimed at inflammatory and fibrotic conditions. The primary mechanism for these treatments is the endocannabinoid system and the agitation of CB2 receptors. The company operates out of Norwood, Massachusetts.

Markets
Exchange Symbol Volume (24h) Volume (%) Price
Nasdaq
CRBP
$137,533,973
100%
$3.3799
Chart
Social media
Tweets by @CorbusPharma
Corbus Pharmaceuticals Holdings Inc.

Share widget

Copy widget code
Subscribe to our newsletter